Monday, October 10, 2016

iRhythm Sets IPO Pricing Range

San Francisco-based iRhythm, which develops cardiac monitoring systems, said in a filing on Friday that it expects it IPO to price at between $13.00 and $15.00 per share. The company is selling 5,350,000 shares of its common stock in its offering, and has applied to list as IRTC on the NASDAQ Global Market. The company's IPO is being underwritten by J.P. Morgan, Morgan Stanley, Canaccord Genuity, and BTIG. iRhythm is backed by Synergy Life Science Partners, Norwest Ventures, Novo A/S, New Leaf, MDV-Relevation, Kaiser Permanente, St. Jude Medical, and others.